^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

HRD

i
Other names: Homologous Recombination Deficiency
Related biomarkers:
HRD
Ovarian Cancer
niraparib
Sensitive
:
A1
ASCO.org - 1 week - (New A2)
HRD
Ovarian Cancer
rucaparib
Sensitive
:
A2
ASCO.org - 1 week - (New A2)
HRD
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
HRD
Peritoneal Cancer
bevacizumab + olaparib
Sensitive
:
A1
HRD
Peritoneal Cancer
niraparib
Sensitive
:
A1
HRD
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
HRD
Ovarian Cancer
bevacizumab + olaparib
Sensitive
:
A1
HRD
Prostate Cancer
olaparib
Sensitive
:
A1
HRD
Ovarian Cancer
olaparib
Sensitive
:
B
HRD
Ovarian Cancer
ABT-888
Sensitive
:
B
HRD
Ovarian Cancer
atezolizumab
Resistant
:
B
HRD
Ovarian Cancer
CPB
Sensitive
:
B
HRD
Breast Cancer
CX-5461
Sensitive
:
B
HRD
Ovarian Cancer
CX-5461
Sensitive
:
B
HRD
Triple Negative Breast Cancer
olaparib
Sensitive
:
C1
HRD
Prostate Cancer
niraparib
Sensitive
:
C1
HRD
Ovarian Cancer
tislelizumab + pamiparib
Sensitive
:
C2
HRD
Triple Negative Breast Cancer
tislelizumab
Sensitive
:
C2
HRD
Ovarian Cancer
bevacizumab + niraparib
Sensitive
:
C2
HRD
Non Small Cell Lung Cancer
talazoparib
Resistant
:
C3
HRD
Gastric Cancer
nivolumab
Sensitive
:
C3
HRD
Triple Negative Breast Cancer
pembrolizumab + niraparib
Sensitive
:
C3
HRD
Prostate Cancer
nivolumab + ipilimumab
Sensitive
:
C3
HRD
Prostate Cancer
abiraterone acetate
Resistant
:
C3
HRD
Ovarian Cancer
ABT-767
Sensitive
:
C3
HRD
Ovarian Cancer
PARP inhibitor
Sensitive
:
C3
HRD
Prostate Cancer
talazoparib
Sensitive
:
C3
HRD
Triple Negative Breast Cancer
carboplatin + paclitaxel + non-pegylated liposomal doxorubicin
Sensitive
:
C3
HRD
Pancreatic Cancer
anlotinib + sintilimab
Sensitive
:
C3
HRD
Squamous Cell Carcinoma of Head and Neck
PD1 inhibitor
Sensitive
:
C3
HRD
Triple Negative Breast Cancer
D19466
Sensitive
:
C3
HRD
Triple Negative Breast Cancer
cisplatin
Sensitive
:
C3
HRD
Triple Negative Breast Cancer
carboplatin
Sensitive
:
C3
HRD
Triple Negative Breast Cancer
carboplatin + docetaxel
Sensitive
:
C3